{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:29Z","timestamp":1786120289025,"version":"build-2736575974"},"reference-count":187,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/dad.0b013e31821b8bfe","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T06:34:43Z","timestamp":1322634883000},"page":"274-284","source":"Crossref","is-referenced-by-count":4,"title":["Comments on Cutaneous Lymphomas"],"prefix":"10.1097","volume":"34","author":[{"given":"Angel","family":"Fernandez-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":". WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.pas.0000153121.57515.c6","article-title":". Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients.","volume":"29","author":"Massone","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":". Defining early mycosis fungoides.","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-0831","article-title":". CD8 CD56 mycosis fungoides with an indolent clinical behaviour: case report and literature review.","volume":"90","author":"Sawada","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/DAD.0b013e31818ffbe8","article-title":"CD4, CD56 mycosis fungoides: case report and review of the literature.","volume":"31","author":"Horst","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-3083.2004.00937.x","article-title":"Clinicopathological spectrum of mycosis fungoides.","volume":"18","author":"Kazakov","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2006.01.020","article-title":". CD4CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.","volume":"55","author":"Hodak","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0560.1998.tb01766.x","article-title":". Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome.","volume":"25","author":"Kamarashev","year":"1998","journal-title":"J Cutan Pathol"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1309\/AJCP7LRRLK8SLUGE","article-title":". Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.","volume":"134","author":"Kelemen","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2133.2008.08761.x","article-title":". The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.","volume":"159","author":"Massone","year":"2008","journal-title":"Br J Dermatol"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archderm.138.2.182","article-title":". Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sezary syndrome.","volume":"138","author":"Cerroni","year":"2002","journal-title":"Arch Dermatol"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1067\/S0190-9622(03)00907-1","article-title":". Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases.","volume":"49","author":"Ardigo","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/PAS.0b013e3182036ce7","article-title":". Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features.","volume":"35","author":"Pileri","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R16-7-20210202","first-page":"540","article-title":"Serini SM, et al..","volume":"20","author":"Cerri","year":"2010","journal-title":"Mycosis fungoides mimicking erythema gyratum repens: an additional variant Eur J Dermatol"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0560.2009.01289.x","article-title":". Diagnosis of mycosis fungoides with different algorithmic approaches.","volume":"37","author":"Furmanczyk","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00000478-200210000-00002","article-title":". Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas.","volume":"26","author":"Scarabello","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archdermatol.2008.46","article-title":". Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC).","volume":"144","author":"Kempf","year":"2008","journal-title":"Arch Dermatol"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":". Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides.","volume":"130","author":"Salgado","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/DAD.0b013e3181b72678","article-title":". Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.","volume":"32","author":"Rasheed","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":". Survival outcomes and prognostic factors in mycosis fungoidesSezary syndrome: validation of the revised International Society for Cutaneous LymphomasEuropean Organisation for Research and Treatment of Cancer staging proposal.","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":". Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","article-title":". Novel and highly recurrent chromosomal alterations in Sezary syndrome.","volume":"68","author":"Vermeer","year":"2008","journal-title":"Cancer Res"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":". Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.","volume":"130","author":"Laharanne","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":". Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","article-title":". MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.","volume":"116","author":"Ballabio","year":"2010","journal-title":"Blood"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1309\/X597G3QMXAFBCM5V","article-title":". First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features.","volume":"123","author":"Wu","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12308-009-0034-z","article-title":"Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms.","volume":"2","author":"Lim","year":"2009","journal-title":"J Hematop"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":". Sezary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).","volume":"64","author":"Olsen","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/jid.2009.301","article-title":". Downregulation of Fas gene expression in Sezary syndrome is associated with promoter hypermethylation.","volume":"130","author":"Jones","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","article-title":". Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.","volume":"116","author":"Kamstrup","year":"2010","journal-title":"Blood"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2340\/00015555-0775","article-title":". ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation.","volume":"90","author":"Ando","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"R34-7-20210202","first-page":"574","article-title":". Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.","volume":"24","author":"Querfeld","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"R35-7-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2007.00778.x","article-title":". The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants.","volume":"35","author":"Massone","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R36-7-20210202","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/DAD.0b013e3181d81dc3","article-title":"Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.","volume":"32","author":"Papalas","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R37-7-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/DAD.0b013e31818779de","article-title":". A distinct entity in the spectrum of the CD30 cutaneous lymphoproliferative diseases: oligolesional nodules with pseudoepitheliomatous hyperplasia followed by spontaneous resolution.","volume":"31","author":"Zayour","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R38-7-20210202","first-page":"315","article-title":"CD30 role in the progression of epithelial tumors Am J Dermatopathol.","volume":"32","author":"Fernandez-Flores","year":"2010","journal-title":""},{"key":"R39-7-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/DAD.0b013e3181c57ec2","article-title":". CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.","volume":"32","author":"Plaza","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R40-7-20210202","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":". The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30 lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"key":"R41-7-20210202","first-page":"680","article-title":". Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.","volume":"137","author":"Herbst","year":"1997","journal-title":"Br J Dermatol"},{"key":"R42-7-20210202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2133.2008.09002.x","article-title":". MUM1 expression does not differentiate primary cutaneous anaplastic large-cell lymphoma and lymphomatoid papulosis.","volume":"160","author":"Hernandez-Machin","year":"2009","journal-title":"Br J Dermatol"},{"key":"R43-7-20210202","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2009.161","article-title":". Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.","volume":"23","author":"Eckerle","year":"2009","journal-title":"Leukemia"},{"key":"R44-7-20210202","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":". Primary and secondary cutaneous CD30() lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"R45-7-20210202","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma.","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"key":"R46-7-20210202","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":". Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"key":"R47-7-20210202","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":". IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R48-7-20210202","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.jaad.2010.02.028","article-title":". A case of indolent CD56-positive lymphomatoid papulosis.","volume":"63","author":"Kim","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R49-7-20210202","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2009.05.014","article-title":". Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients.","volume":"61","author":"de Souza","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R51-7-20210202","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":". A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8 cytotoxic T-cell lymphoma. Description of 9 cases.","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R52-7-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0560.2002.290507.x","article-title":". Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.","volume":"29","author":"Kempf","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"suppl 1","key":"R54-7-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0001-7310(09)73164-3","article-title":"Cutaneous lymphomas: from morphology to chip technology.","volume":"100","author":"Cerroni","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"R55-7-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2559.2009.03455.x","article-title":"Classification of cutaneous lymphomasan update.","volume":"56","author":"Kempf","year":"2010","journal-title":"Histopathology"},{"key":"R56-7-20210202","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1529-8019.2010.01335.x","article-title":"Subcutaneous lymphoma and related conditions.","volume":"23","author":"Guitart","year":"2010","journal-title":"Dermatol Ther"},{"key":"R57-7-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":". Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alphabeta and gammadelta subtypes.","volume":"22","author":"Salhany","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R58-7-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":". Subcutaneous, blastic natural killer (NK), NKT-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R59-7-20210202","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/DAD.0b013e318182c7bf","article-title":". Fatal subcutaneous panniculitis-like T-cell lymphoma gammadelta subtype (cutaneous gammadelta T-cell lymphoma): report of a case and review of the literature.","volume":"30","author":"Kao","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"R60-7-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.0303-6987.2006.00493.x","article-title":". The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.","volume":"33","author":"Massone","year":"2006","journal-title":"J Cutan Pathol"},{"key":"R61-7-20210202","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1309\/TYRGT196N2APLLR9","article-title":". Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD56- or CD56 lymphoma and review of 44 other reported cases.","volume":"121","author":"Takeshita","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R62-7-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.humpath.2003.09.015","article-title":". Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan.","volume":"35","author":"Takeshita","year":"2004","journal-title":"Hum Pathol"},{"key":"R63-7-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1440-1827.1999.00854.x","article-title":". A case of natural killerT cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma.","volume":"49","author":"Yamashita","year":"1999","journal-title":"Pathol Int"},{"key":"R64-7-20210202","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":". Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"R65-7-20210202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0190-9622(03)02784-1","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis.","volume":"50","author":"Cassis","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R66-7-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.0303-6987.2005.00331.x","article-title":"Fatal subcutaneous panniculitis-like T-cell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus.","volume":"32","author":"Ma","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R67-7-20210202","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2006.08.029","article-title":". Cutaneous gammadelta T-cell lymphoma: a histopathologic mimicker of lupus erythematosus profundus (lupus panniculitis).","volume":"56","author":"Aguilera","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R68-7-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10067-005-0125-x","article-title":". Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis.","volume":"26","author":"Gonzalez","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R69-7-20210202","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":". Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients.","volume":"99","author":"Fink-Puches","year":"2002","journal-title":"Blood"},{"key":"R70-7-20210202","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.0303-6987.2005.00351.x","article-title":". Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases.","volume":"32","author":"Massone","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R72-7-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/DAD.0b013e3181b4a5ec","article-title":". Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies.","volume":"32","author":"Park","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R73-7-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0560.2001.028005235.x","article-title":". Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia.","volume":"28","author":"Magro","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R74-7-20210202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1600-0560.2007.00938.x","article-title":". Atypical lymphocytic lobular panniculitis: a clonal subcutaneous T-cell dyscrasia.","volume":"35","author":"Magro","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R75-7-20210202","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/jid.2008.6","article-title":". Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma.","volume":"128","author":"Hahtola","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R76-7-20210202","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1158\/0008-5472.CAN-04-0366","article-title":". Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.","volume":"65","author":"Karenko","year":"2005","journal-title":"Cancer Res"},{"key":"R78-7-20210202","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pbc.22489","article-title":". CD56-negative extranodal nasal type NKT-cell lymphoma.","volume":"55","author":"Miles","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R79-7-20210202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NKT cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"R80-7-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1309\/V561QTM6854W4WAV","article-title":". Immunohistochemical characterization of nasal-type extranodal NKT-cell lymphoma using a tissue microarray: an analysis of 84 cases.","volume":"130","author":"Schwartz","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R81-7-20210202","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":". CD56 hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"key":"R82-7-20210202","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":". Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"R83-7-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":". Primary non-Hodgkins lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"R84-7-20210202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00000478-199905000-00012","article-title":". Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases.","volume":"23","author":"Natkunam","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R85-7-20210202","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":". Nasal-type extranodal natural killerT-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore.","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"R86-7-20210202","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdq347","article-title":". Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NKT-cell lymphoma.","volume":"22","author":"Wang","year":"2011","journal-title":"Ann Oncol"},{"key":"R87-7-20210202","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.2008.08922.x","article-title":". Extranodal NKT-cell lymphoma with cutaneous involvement: nasal vs. nasal-type subgroups-a retrospective study of 18 patients.","volume":"160","author":"Choi","year":"2009","journal-title":"Br J Dermatol"},{"key":"R88-7-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2009-11-252957","article-title":". Cutaneous extranodal NKT-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization.","volume":"116","author":"Berti","year":"2010","journal-title":"Blood"},{"key":"R89-7-20210202","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","article-title":"Cutaneous T cell lymphoma with suppressorcytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.","volume":"22","author":"Agnarsson","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R90-7-20210202","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000372-199012000-00012","article-title":". Cytotoxicsuppressor (CD8, CD4-) cutaneous T-cell lymphoma with aggressive course.","volume":"12","author":"Urrutia","year":"1990","journal-title":"Am J Dermatopathol"},{"key":"R91-7-20210202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00000372-199506000-00012","article-title":". Rapidly progressive CD8-positive cutaneous T-cell lymphoma with tongue involvement.","volume":"17","author":"Quarterman","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"R92-7-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":". Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"R93-7-20210202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncr.11107","article-title":". Cytotoxicnatural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.","volume":"97","author":"Santucci","year":"2003","journal-title":"Cancer"},{"key":"R94-7-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000087025","article-title":". Fatal CD8 epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.","volume":"211","author":"Marzano","year":"2005","journal-title":"Dermatology"},{"key":"R95-7-20210202","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0190-9622(03)00065-3","article-title":". Progressive epidermotropic CD8CD4- primary cutaneous CD30 lymphoproliferative disorder in a patient with sarcoidosis.","volume":"51","author":"Gelfand","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R96-7-20210202","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1346-8138.2006.00147.x","article-title":"Primary cutaneous aggressive epidermotropic CD8() cytotoxic T-cell lymphoma with atypical presentation.","volume":"33","author":"Kim","year":"2006","journal-title":"J Dermatol"},{"key":"R97-7-20210202","first-page":"354","article-title":". EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"R98-7-20210202","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archderm.144.8.1027","article-title":". CD8 epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.","volume":"144","author":"Introcaso","year":"2008","journal-title":"Arch Dermatol"},{"key":"R99-7-20210202","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jcp.2007.054585","article-title":". Rare provisional entity: primary cutaneous aggressive epidermotropic CD8 cytotoxic T-cell lymphoma in a young woman.","volume":"61","author":"Csomor","year":"2008","journal-title":"J Clin Pathol"},{"key":"R101-7-20210202","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1309\/AJCPMG37MXKYPUBE","article-title":". Percentage of gammadelta T cells in panniculitis by paraffin immunohistochemical analysis.","volume":"131","author":"Roullet","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R102-7-20210202","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study.","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"R103-7-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":". Primary cutaneous CD4 small-medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance A study of 136 cases.","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R104-7-20210202","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":". Primary cutaneous CD4-positive smallmedium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"key":"R105-7-20210202","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":". Primary cutaneous smallmedium CD4 T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"key":"R106-7-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":". Primary cutaneous CD4 smallmedium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R107-7-20210202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.dad.0000210389.36724.dd","article-title":". Pleomorphic CD8 smallmedium size cutaneous T-cell lymphoma.","volume":"28","author":"Khamaysi","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"R108-7-20210202","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2559.2010.03498.x","article-title":". Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases.","volume":"56","author":"Le Tourneau","year":"2010","journal-title":"Histopathology"},{"key":"R109-7-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0560.2010.01647.x","article-title":". Indolent CD8 lymphoid proliferation of the ear: report of two cases and review of the literature.","volume":"38","author":"Swick","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R111-7-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S0022215106005457","article-title":". Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.","volume":"121","author":"Fika","year":"2007","journal-title":"J Laryngol Otol"},{"key":"R112-7-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2559.2009.03383.x","article-title":". Indolent CD8 lymphoid proliferation of the ear: a new entity and possible occurrence of signet ring cells.","volume":"55","author":"Li","year":"2009","journal-title":"Histopathology"},{"key":"R113-7-20210202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2133.2010.10105.x","article-title":"Primary cutaneous CD8() small-medium-sized pleomorphic T-cell lymphoma, ear-type: a unique CTCL with a favourable prognosis.","volume":"164","author":"Geraud","year":"2011","journal-title":"Br J Dermatol"},{"key":"R115-7-20210202","first-page":"81","article-title":"Cerroni L. Indolent CD8 lymphoid proliferation of the ear: A phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma J Cutan Pathol.","volume":"37","author":"Beltraminelli","year":"2010","journal-title":""},{"key":"R116-7-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","article-title":"Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.","volume":"14","author":"Martin","year":"2001","journal-title":"Immunity"},{"key":"R117-7-20210202","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":". Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.","volume":"20","author":"Bailey","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R118-7-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":". Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"suppl","key":"R119-7-20210202","first-page":"S38","article-title":". Primary cutaneous marginal zone B-cell lymphoma.","volume":"125","author":"Cho-Vega","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R120-7-20210202","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-200009000-00012","article-title":". Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.","volume":"24","author":"Goodlad","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R121-7-20210202","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(97)80405-7","article-title":". Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a.","volume":"36","author":"Kutting","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R122-7-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","article-title":". Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin.","volume":"31","author":"Roggero","year":"2000","journal-title":"Hum Pathol"},{"key":"R123-7-20210202","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","article-title":". Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States.","volume":"21","author":"Takino","year":"2008","journal-title":"Mod Pathol"},{"key":"R124-7-20210202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":". Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.","volume":"28","author":"Wood","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R125-7-20210202","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0190-9622(91)70088-J","article-title":". Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.","volume":"24","author":"Garbe","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"R126-7-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000106580","article-title":"Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report.","volume":"215","author":"Monari","year":"2007","journal-title":"Dermatology"},{"key":"R127-7-20210202","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jid.2008.243","article-title":". Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.","volume":"129","author":"Deutsch","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R128-7-20210202","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R129-7-20210202","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":". The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"R130-7-20210202","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.2372","article-title":". Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.","volume":"215","author":"Deutsch","year":"2008","journal-title":"J Pathol"},{"key":"R131-7-20210202","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V95.2.627","article-title":". The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.","volume":"95","author":"Jones","year":"2000","journal-title":"Blood"},{"key":"R132-7-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1042819031000060546","article-title":". Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism.","volume":"44","author":"Ohshima","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R133-7-20210202","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.20823","article-title":". CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone.","volume":"114","author":"Suefuji","year":"2005","journal-title":"Int J Cancer"},{"key":"R134-7-20210202","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1349-7006.2008.00883.x","article-title":". Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.","volume":"99","author":"Yamamoto","year":"2008","journal-title":"Cancer Sci"},{"key":"R135-7-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1309\/AJCPW64FFBTTPKFN","article-title":". Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.","volume":"133","author":"Geyer","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R136-7-20210202","first-page":"504","article-title":"Porcu P, et al..","volume":"30","author":"Magro","year":"2003","journal-title":"Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application J Cutan Pathol"},{"key":"R137-7-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/PAS.0b013e3181a6ae1e","article-title":". CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications.","volume":"33","author":"Kutzner","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R138-7-20210202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/DAD.0b013e3181aff9b3","article-title":"CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: A crucial role and a new lymphoma paradigm.","volume":"32","author":"Kempf","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R139-7-20210202","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":". T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"R140-7-20210202","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":". Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites.","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"R141-7-20210202","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2005-08-3443","article-title":". Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.","volume":"107","author":"Dijkman","year":"2006","journal-title":"Blood"},{"key":"R142-7-20210202","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":". Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R143-7-20210202","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":". Primary cutaneous follicle center cell lymphoma with follicular growth pattern.","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"key":"R144-7-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000372-200402000-00002","article-title":". Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.","volume":"26","author":"Leinweber","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"R145-7-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/DAD.0b013e3181b8c377","article-title":". Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.","volume":"32","author":"Fierro","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R146-7-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2559.2009.03455.x","article-title":"Classification of cutaneous lymphomasan update.","volume":"56","author":"Kempf","year":"2010","journal-title":"Histopathology"},{"key":"R149-7-20210202","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200107000-00005","article-title":". Cutaneous follicular B-cell lymphoma: description of a series of 18 cases.","volume":"25","author":"Franco","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R150-7-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":". Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R151-7-20210202","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":". Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"R152-7-20210202","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/jid.2009.418","article-title":". IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type.","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R153-7-20210202","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":". IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R154-7-20210202","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":". Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"R155-7-20210202","first-page":"213","article-title":". FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.","volume":"26","author":"Espinet","year":"2011","journal-title":"Histol Histopathol"},{"key":"R156-7-20210202","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":". Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type.","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R157-7-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s004280100398","article-title":". Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma.","volume":"439","author":"Kanda","year":"2001","journal-title":"Virchows Arch"},{"key":"R158-7-20210202","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":". Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"R159-7-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/DAD.0b013e31816c745f","article-title":". Intravascular B-cell lymphoma: the role of skin biopsy.","volume":"30","author":"Barnett","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"R161-7-20210202","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/theoncologist.11-5-496","article-title":"Intravascular lymphoma: the oncologists great imitator.","volume":"11","author":"Zuckerman","year":"2006","journal-title":"Oncologist"},{"key":"R162-7-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jcp.50.1.67","article-title":". Angiotropic lymphoma: report of a case with histiocytic features.","volume":"50","author":"Snowden","year":"1997","journal-title":"J Clin Pathol"},{"key":"R163-7-20210202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ajcp\/112.2.248","article-title":". Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy.","volume":"112","author":"Estalilla","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R164-7-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12185-009-0458-3","article-title":". A case of intravascular large B-cell lymphoma of the cutaneous variant: the first case in Asia.","volume":"91","author":"Kameoka","year":"2010","journal-title":"Int J Hematol"},{"key":"R165-7-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":". Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the cutaneous variant.","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"R166-7-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.2007.07954.x","article-title":"Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin.","volume":"157","author":"Roglin","year":"2007","journal-title":"Br J Dermatol"},{"key":"R167-7-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":". Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R168-7-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":". Blastic NK-cell lymphomas (agranular CD4CD56 hematodermic neoplasms): a review.","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R169-7-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4CD56 hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R170-7-20210202","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/W9Q5AGYDE5LANN39","article-title":". CD4CD56 hematodermic neoplasm (blastic natural killer cell lymphoma): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.","volume":"128","author":"Pilichowska","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R171-7-20210202","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":". Novel markers of normal and neoplastic human plasmacytoid dendritic cells.","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"R172-7-20210202","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jcp.2006.042135","article-title":". CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.","volume":"60","author":"Assaf","year":"2007","journal-title":"J Clin Pathol"},{"key":"R173-7-20210202","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1080\/10428190410001723232","article-title":". Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.","volume":"45","author":"Argyrakos","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R174-7-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-0560.2007.00915.x","article-title":". CD4-negative variant of CD4CD56 hematodermic neoplasm: description of three cases.","volume":"35","author":"Ascani","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R175-7-20210202","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":". CD4() CD56() lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R176-7-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0145-2126(01)00198-9","article-title":". Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases.","volume":"26","author":"Momoi","year":"2002","journal-title":"Leuk Res"},{"key":"R177-7-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2004.05713.x","article-title":". A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4CD56 haematodermic neoplasm).","volume":"150","author":"Petrella","year":"2004","journal-title":"Br J Dermatol"},{"key":"R178-7-20210202","first-page":"369","article-title":"CD56-negative blastic natural killer-cell lymphoma (agranular CD4()CD56() haematodermic neoplasm) Br J Dermatol.","volume":"152","author":"Kawai","year":"2005","journal-title":""},{"key":"R179-7-20210202","first-page":"281","article-title":". New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues.","volume":"10","author":"Falini","year":"2010","journal-title":"Discov Med"},{"key":"R180-7-20210202","first-page":"869","article-title":"Burg G, et al..","volume":"149","author":"Kazakov","year":"2003","journal-title":"Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more Br J Dermatol"},{"key":"R181-7-20210202","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":". Clinical and biologic features of CD4()CD56() malignancies.","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"},{"key":"R182-7-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3324\/haematol.13855","article-title":". Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.","volume":"94","author":"Facchetti","year":"2009","journal-title":"Haematologica"},{"key":"R183-7-20210202","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/jid.2009.369","article-title":". Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.","volume":"130","author":"Wiesner","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R185-7-20210202","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/PAS.0b013e3181fbb4fd","article-title":". EBV-associated cutaneous NKT-cell lymphoma: review of a series of 14 cases from peru in children and young adults.","volume":"34","author":"Rodriguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R186-7-20210202","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-4632.2007.03102.x","article-title":". Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.","volume":"46","author":"Wu","year":"2007","journal-title":"Int J Dermatol"},{"key":"R187-7-20210202","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":". Clinical differences between nasal and extranasal natural killerT-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"R188-7-20210202","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":". Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, September 8-9, 2008.","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"R189-7-20210202","first-page":"364","article-title":"Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.","volume":"18","author":"Feng","year":"2008","journal-title":"Eur J Dermatol"},{"key":"R190-7-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(99)70210-0","article-title":". Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy.","volume":"40","author":"Iwatsuki","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R191-7-20210202","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":". The association of latent Epstein-Barr virus infection with hydroa vacciniforme.","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"key":"R192-7-20210202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0923-1811(99)00084-5","article-title":". Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview.","volume":"22","author":"Iwatsuki","year":"2000","journal-title":"J Dermatol Sci"},{"key":"R194-7-20210202","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1600-0560.2007.00859.x","article-title":". A case of primary Epstein-Barr virus-associated cutaneous diffuse large B-cell lymphoma unassociated with iatrogenic or endogenous immune dysregulation.","volume":"35","author":"Tokuda","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R195-7-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/DAD.0b013e3181ba9e4f","article-title":". A case of primary cutaneous senile EBV-related diffuse large B-cell lymphoma.","volume":"32","author":"Martin","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R196-7-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1600-0560.2009.01449.x","article-title":". Cutaneous presentation of post-renal transplant lymphoproliferative disorder: a series of four cases.","volume":"37","author":"Salama","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R197-7-20210202","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/DAD.0b013e3181d68381","article-title":". Primary cutaneous epstein-barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.","volume":"32","author":"Park","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R198-7-20210202","first-page":"851","article-title":". Primary cutaneous angioimmunoblastic T-cell lymphoma histologically mimicking an inflammatory dermatosis.","volume":"9","author":"Smithberger","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R199-7-20210202","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1600-0560.2009.01408.x","article-title":". Multiple cutaneous monoclonal B-cell proliferations as harbingers of systemic angioimmunoblastic T-cell lymphoma.","volume":"37","author":"Bayerl","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R200-7-20210202","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00428-005-0080-6","article-title":". Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression.","volume":"447","author":"Takahashi","year":"2005","journal-title":"Virchows Arch"},{"key":"R201-7-20210202","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/PAS.0b013e31815d29c9","article-title":". Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection.","volume":"32","author":"Cerroni","year":"2008","journal-title":"Am J Surg Pathol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0b013e31821b8bfe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:25:00Z","timestamp":1786047900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-201205000-00007"}},"subtitle":["Since the WHO-2008 Classification to Present"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31821b8bfe","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}